This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shire Human Genetic Therapies, Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovations of Matthew Traylor
Introduction
Matthew Traylor is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of medical science, particularly in the treatment of hypertriglyceridemic-related conditions. His work focuses on developing innovative solutions to combat serious health issues.
Latest Patents
Matthew Traylor holds a patent for a lipoprotein lipase (LPL) protein aimed at treating and preventing hypertriglyceridemia (HTG) and its associated diseases. This includes conditions such as acute pancreatitis, cardiovascular diseases, metabolic disorders, endocrine disorders, and fat embolism syndrome. His patent represents a crucial advancement in medical therapies for these serious health conditions.
Career Highlights
Traylor is currently employed at Shire Human Genetic Therapies, Inc., where he continues to work on groundbreaking research and development projects. His expertise in lipoprotein lipase has positioned him as a key figure in the medical research community.
Collaborations
He collaborates with notable colleagues, including Omar L. Francone and Lin Guey, to further enhance the impact of his research and innovations. Their combined efforts contribute to the advancement of therapeutic solutions in the field.
Conclusion
Matthew Traylor's work exemplifies the spirit of innovation in medical science. His contributions through his patent and collaborations are paving the way for improved treatments for hypertriglyceridemic-related conditions.